Inflammation in Tumorigenesis and Cancer Treatment

Nyhet

From Molecular Mechanisms to Personalized Therapeutic Strategies

Häftad, Engelska, 2026

2 249 kr

Kommande

Inflammation in Tumorigenesis and Cancer Treatment: From Molecular Mechanisms to Personalized Therapeutic Strategies explores the pivotal role of inflammation in cancer. This authoritative guide uncovers the molecular dialogue between inflammatory factors and tumor cells, illuminating pathways that drive oncogenesis and metastasis. Highlighting the rapid pace of discovery in this field, it bridges the gap by translating complex data into actionable clinical strategies, catering to the educational needs of students and professionals, and addressing the burgeoning field of personalized medicine. The book is organized into five key sections. The first includes chapters on the fundamental concepts of inflammation in cancer and recent advances in research. The second reviews the impact of inflammatory mediators on signaling pathways and oncogenesis. Section III explores therapeutic strategies targeting inflammatory pathways and the role of immunometabolism, while Section IV discusses biomarker discovery and personalized treatment plans. The final section examines the tumor microenvironment, the microbiome's role, and the intersection of immunotherapy and inflammation. Inflammation in Tumorigenesis and Cancer Treatment: From Molecular Mechanisms to Personalized Therapeutic Strategies offers numerous benefits to its audience. For scientists and researchers, it provides cutting-edge knowledge to inspire new research directions and foster interdisciplinary collaboration, while serving as a valuable educational tool for the next generation of researchers. The book offers a deeper understanding of inflammation's role in cancer, facilitating more precise and personalized treatment strategies. It helps clinicians stay current with the latest research and improve patient outcomes through better-informed decision-making. Ultimately, this book empowers its readers with the knowledge to advance cancer care and contribute to the forefront of medical science.

Provides the latest insights into inflammation's role in cancer
Provides an interdisciplinary in-depth analysis that reveals the molecular mechanisms of inflammatory mediators in tumor development
Drives new research directions, ideas, and innovative approaches
Offers strategies for developing personalized treatment plans based on a patient’s unique inflammatory profile
Enhances clinicians' ability to make informed decisions, improving patient outcomes with the latest therapeutic approaches

Produktinformation

Utgivningsdatum2026-08-01
Mått191 x 235 x undefined mm
Vikt450 g
FormatHäftad
SpråkEngelska
SerieTranslational Immunology
Antal sidor250
FörlagElsevier Science
ISBN9780443366499

Tillhör följande kategorier

Onkologi inom Medicin

Dr. Mowei Kong, MD, is a seasoned medical professional with a rich background in endocrinology, metabolism, oncology, and cardiovascular diseases. He previously served as a clinical physician at Guiqian International Hospital and is currently engaged in basic research at Southwest Medical College. Dr. Kong's expertise spans Type 2 Diabetes, insulin resistance, obesity, gastrointestinal and cardiac tumors, and coronary heart disease. Some notable works include studies on CTRP6's role in digestive system tumors and GLP-1 receptor agonists' effects on lipotoxicity.His experience in these areas highlights his ability to analyze signal transduction pathways, identify new therapeutic targets, and translate basic scientific research into clinical applications. Dr. Kong's comprehensive experience in both clinical practice and research enables him to provide valuable insights and advancements in the understanding and treatment of cancer and related conditions.Dr. Chunxiang Zhang is a distinguished cardiologist and academic leader with extensive international experience in cardiology and oncology. He holds a Doctor of Cardiology degree and completed his postdoctoral fellowship in cardiovascular pharmacology in the US. Currently serving as the Deputy Secretary of the Party Committee and President of Southwest Medical University, he also directs the Key Laboratory of the Ministry of Education. His career spans over three decades, including ten years in top cardiology departments in China and 22 years in the US, where he held prestigious positions at the University of Tennessee and Rush University. Dr. Zhang's research delves into the molecular mechanisms of tumorigenesis, inflammation, and cancer therapies, with notable work on tetraspanins in digestive system cancers and innovative therapeutic strategies. His comprehensive research and publications provide valuable insights into signaling pathways, biomarkers, and clinical implications, making him a key figure in advancing cancer treatment and understanding.

Section I. Foundational Concepts1. Introduction2. Recent Advances and Future Research Directions in the Crosstalk Between Inflammation and TumorsSection II. Signaling Pathways and the Dynamics3. Signaling Pathways, Inflammatory Mediators, and OncogenesisSection III. Translational Research and Therapeutic Targets4. Targeting Inflammatory Pathways for Cancer Therapy5. Immunometabolism and Its Implications for Cancer Research6. Emerging Technologies and Future Research Directions in Inflammation and Cancer ResearchSection IV. Biomarkers and Personalized Medicine7. Biomarker Discovery and Validation in Inflammatory Cancer Research8. Personalized Medicine Utilizing BiomarkersSection V. Clinical Implications and Therapeutic Strategies9. Inflammation and Tumor Microenvironment10. The Microbiome's Role in Systemic Inflammation, Immune Responses, and Tumor Microenvironment11. Immunotherapy and Inflammation Management